Skip to main content

Kardigan, Inc 8-K, filed Nov 6, 2026

Kardigan, Inc. (KARD)

8-K 2026-11-06 For: 2026-11-06
View Original
Added on November 06, 2026

About this 8-K

Kardigan, Inc filed this 8-K on November 6, 2026.

Kardigan completed enrollment in its Phase 2b KATALYST-AV trial of ataciguat for aortic stenosis, moving primary endpoint assessment to Week 48 and topline data to 2H 2027. AI summary

Items reported

  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits